Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.

Leave a Reply

Your email address will not be published. Required fields are marked *